Introduction: Osteoporosis is a well-recognized complication of Cushing's syndrome (CS). Data on bone health in patients with CS from south Asian countries, which are vitamin D deficient, are scarce. Aims: We assessed bone mineral density (BMD) in patients with CS in comparison to controls. We also looked into how BMD differs in different types of endogenous CS. Materials and Methods: Thirty-seven cases of CS and 48 matched controls were studied for clinical, biochemical, hormonal, and bone densitometry parameters. Results: BMD (both total lumbar spine (LS) and hip) as well as Z scores were significantly lower in CS patients as compared to controls. Neither LS nor hip BMD was significantly different among different etiological groups of CS....
Patients with Cushing's syndrome (CS) develop osteopenia-osteoporosis. The present study evaluates t...
Overt hypercortisolism causes reduction in bone mass and density. The effects of subclinical Cushing...
Objective: It is well known that patients with endogenous Cushing’s syndrome (CS) have decreased bon...
Background: Patients with Cushing's syndrome have a high prevalence of osteoporotic fractures. Littl...
BACKGROUND: Osteoporosis is an important, frequently unrecognized consequence of hypercortisolism. O...
OBJECTIVE: Cushing's syndrome (CS) is associated with osteoporosis and high fracture risk. Besides m...
SUMMARY: This is the first study examining the impact of both clinical, biochemical, and genetic det...
BACKGROUND: Osteoporosis is a frequent, severe and often underestimated consequence of long-term hyp...
In a cohort study of 182 consecutive patients with active endogenous Cushing's syndrome, the only pr...
OBJECTIVE: Cushing's syndrome (CS) is a well recognized cause of bone loss. Although many previous s...
The present study was designed to evaluate the relationship between bone traits [bone mineral densit...
OBJECTIVE: Cushing's syndrome (CS) is a well recognized cause of bone loss. Although many previous s...
Abstract OBJECTIVE: The aim of this study was to compare bone turnover and mass in women with eith...
The aim of the present investigation was to study the effect of glucocorticoid excess on bone mass a...
International audienceOBJECTIVE: Glucocorticoid excess is one of the most important causes of bone d...
Patients with Cushing's syndrome (CS) develop osteopenia-osteoporosis. The present study evaluates t...
Overt hypercortisolism causes reduction in bone mass and density. The effects of subclinical Cushing...
Objective: It is well known that patients with endogenous Cushing’s syndrome (CS) have decreased bon...
Background: Patients with Cushing's syndrome have a high prevalence of osteoporotic fractures. Littl...
BACKGROUND: Osteoporosis is an important, frequently unrecognized consequence of hypercortisolism. O...
OBJECTIVE: Cushing's syndrome (CS) is associated with osteoporosis and high fracture risk. Besides m...
SUMMARY: This is the first study examining the impact of both clinical, biochemical, and genetic det...
BACKGROUND: Osteoporosis is a frequent, severe and often underestimated consequence of long-term hyp...
In a cohort study of 182 consecutive patients with active endogenous Cushing's syndrome, the only pr...
OBJECTIVE: Cushing's syndrome (CS) is a well recognized cause of bone loss. Although many previous s...
The present study was designed to evaluate the relationship between bone traits [bone mineral densit...
OBJECTIVE: Cushing's syndrome (CS) is a well recognized cause of bone loss. Although many previous s...
Abstract OBJECTIVE: The aim of this study was to compare bone turnover and mass in women with eith...
The aim of the present investigation was to study the effect of glucocorticoid excess on bone mass a...
International audienceOBJECTIVE: Glucocorticoid excess is one of the most important causes of bone d...
Patients with Cushing's syndrome (CS) develop osteopenia-osteoporosis. The present study evaluates t...
Overt hypercortisolism causes reduction in bone mass and density. The effects of subclinical Cushing...
Objective: It is well known that patients with endogenous Cushing’s syndrome (CS) have decreased bon...